Abstract CT174: First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: Phase 1 results

MLA

Shivaani Kummar, et al. “Abstract CT174: First-in-Class Anti-CD200R1 Antibody 23ME-00610 in Patients with Advanced Solid Malignancies: Phase 1 Results.” Cancer Research, vol. 83, Apr. 2023, p. CT174. EBSCOhost, https://doi.org/10.1158/1538-7445.am2023-ct174.

APA

Shivaani Kummar, Albiruni ABDUL RAZAK, Scott Laurie, Sariah Kell, Dylan Glatt, Sophia R. Majeed, & Drew Rasco. (2023). Abstract CT174: First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: Phase 1 results. Cancer Research, 83, CT174. https://doi.org/10.1158/1538-7445.am2023-ct174

Chicago

Shivaani Kummar, Albiruni ABDUL RAZAK, Scott Laurie, Sariah Kell, Dylan Glatt, Sophia R. Majeed, and Drew Rasco. 2023. “Abstract CT174: First-in-Class Anti-CD200R1 Antibody 23ME-00610 in Patients with Advanced Solid Malignancies: Phase 1 Results.” Cancer Research 83 (April): CT174. doi:10.1158/1538-7445.am2023-ct174.